We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+2.61%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$50.2B
AUM Growth
+$3.92B
Cap. Flow
+$564M
Cap. Flow %
1.12%
Top 10 Hldgs %
16.03%
Holding
4,663
New
353
Increased
1,075
Reduced
2,687
Closed
125

Sector Composition

Rank Sector Weight
1 Technology 8.51%
2 Financials 5.78%
3 Consumer Discretionary 5.73%
4 Healthcare 5.19%
5 Communication Services 4.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVLP
4051
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$6.86K ﹤0.01%
+1,804
New +$6K
SH icon
4052
ProShares Short S&P500
SH
$846M
$6.84K ﹤0.01%
64
QIWI
4053
DELISTED
QIWI PLC
QIWI
$6.81K ﹤0.01%
+348
New +$5.58K
RNAC icon
4054
Cartesian Therapeutics
RNAC
$257M
$6.8K ﹤0.01%
127
-121
-49% -$8.25K
CRVS icon
4055
Corvus Pharmaceuticals
CRVS
$1.2B
$6.75K ﹤0.01%
1,806
-1,337
-43% -$5.24K
RMNI icon
4056
Rimini Street
RMNI
$450M
$6.75K ﹤0.01%
1,274
-1,091
-46% -$5.5K
MFIN icon
4057
Medallion Financial
MFIN
$255M
$6.71K ﹤0.01%
+995
New +$6.83K
LQDA icon
4058
Liquidia Corp
LQDA
$7.9B
$6.68K ﹤0.01%
835
-679
-45% -$6.38K
NHTC icon
4059
Natural Health Trends
NHTC
$14.8M
$6.53K ﹤0.01%
811
-723
-47% -$7.56K
PROV icon
4060
Provident Financial
PROV
$113M
$6.51K ﹤0.01%
310
+282
+1,007% +$5.73K
NVTR
4061
DELISTED
Nuvectra Corporation Common Stock
NVTR
$6.5K ﹤0.01%
1,941
-1,668
-46% -$10.6K
ACGN
4062
DELISTED
Aceragen Inc
ACGN
$6.45K ﹤0.01%
142
-109
-43% -$5.16K
HARP
4063
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$6.45K ﹤0.01%
+50
New +$5.81K
ZVO
4064
DELISTED
Zovio Inc. Common Stock
ZVO
$6.41K ﹤0.01%
1,790
-478
-21% -$2.38K
ALC icon
4065
Alcon
ALC
$36.5B
$6.39K ﹤0.01%
+103
New +$6.05K
FNCB
4066
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
$6.39K ﹤0.01%
+825
New +$6.36K
SRT
4067
DELISTED
Startek Inc.
SRT
$6.38K ﹤0.01%
781
+496
+174% +$3.79K
ARL icon
4068
American Realty Investors
ARL
$248M
$6.36K ﹤0.01%
466
-9
-2% -$115
ROAD icon
4069
Construction Partners
ROAD
$6.69B
$6.28K ﹤0.01%
+418
New +$5.46K
NCSM icon
4070
NCS Multistage Holdings
NCSM
$134M
$6.25K ﹤0.01%
88
-29
-25% -$2.16K
VRDN icon
4071
Viridian Therapeutics
VRDN
$2.67B
$6.19K ﹤0.01%
201
-167
-45% -$6.7K
DWSN icon
4072
Dawson Geophysical
DWSN
$136M
$6.16K ﹤0.01%
2,462
-2,019
-45% -$5.01K
CBAN icon
4073
Colony Bankcorp
CBAN
$467M
$6.07K ﹤0.01%
+358
New +$6.1K
GMLP
4074
DELISTED
Golar LNG Partners LP
GMLP
$6.05K ﹤0.01%
535
TTOO
4075
DELISTED
T2 Biosystems, Inc
TTOO
$6.04K ﹤0.01%
1

Similar funds

BNP Paribas Financial Markets's Q2 2019 Portfolio in Review

As of Q2 2019, BNP Paribas Financial Markets held 4,663 positions worth $50.2B, up 8.5% from $46.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

BNP Paribas Financial Markets's Q2 2019 filing shows 353 new, 1,075 increased, 2,687 reduced and 125 closed positions. Its largest new stake was Cigna: 315,599 shares worth $49.7M. The largest sale was Invesco QQQ Trust, an estimated $995M.

By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.6% a quarter earlier, followed by Financials and Consumer Discretionary.

  • BNP Paribas Financial Markets's largest Q2 2019 buy was Cigna: 315,599 shares worth $49.7M.
  • BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $478M increase.
  • BNP Paribas Financial Markets's biggest Q2 2019 reduction was Invesco QQQ Trust, cutting an estimated $995M.
  • BNP Paribas Financial Markets fully exited ARRIS International plc Ordinary Shares in Q2 2019, selling an estimated $40.4M.
  • BNP Paribas Financial Markets's ten largest holdings make up 16% of its $50.2B portfolio in Q2 2019.
  • BNP Paribas Financial Markets opened 353 new positions and closed 125 in Q2 2019.
  • BNP Paribas Financial Markets's portfolio value rose 8.5% quarter-over-quarter to $50.2B.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2019, filed 30 Jul 2019.